Page last updated: 2024-10-17

cytosine and Papillomavirus Infections

cytosine has been researched along with Papillomavirus Infections in 100 studies

Papillomavirus Infections: Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.

Research Excerpts

ExcerptRelevanceReference
"No recurrence was observed in nine patients over an average follow-up period of 24."2.69Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study. ( Calista, D, 2000)
" This study reviews the published dosing regimens of intralesional cidofovir in the treatment of RRP in order to provide a precedent for those that wish to prescribe it."2.49Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis. ( Clamp, PJ; Saunders, MW, 2013)
"Imiquimod was released recently for therapy of genital warts."2.40Therapy of human papillomavirus infection and associated epithelial tumors. ( Gross, G, 1997)
"To evaluate the recurrence pattern, the larynx was divided into 10 subsites, and patients were investigated for the frequency of recurrence at the subsites after the operation."1.43Is recurrent respiratory papillomatosis a manageable or curable disease? ( Baizhumanova, AS; Kim, HT, 2016)
"Human papillomavirus (HPV) causes cervical cancer and a large fraction of head and neck squamous cell carcinomas (HNSCC)."1.43Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms. ( Andrei, G; Mertens, B; Naesens, L; Nogueira, T; Snoeck, R; Stranska, R, 2016)
"Problem of treatment is the high recurrence of papilloma growth after surgical removal; therefore adjuvant therapy schemes have been established."1.39Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis. ( Friedrich, G; Graupp, M; Gugatschka, M; Hammer, G; Kiesler, K; Reckenzaun, E, 2013)
" Administration should remain below established safe limits of dosing (3 mg/kg) and volume."1.39Current use of intralesional cidofovir for recurrent respiratory papillomatosis. ( Chadha, NK; Derkay, CS; Froehlich, P; McMurray, JS; Pransky, SM; Rosen, CA; Volsky, PG, 2013)
"Condyloma, also known as venereal warts, are caused by human papillomavirus (HPV)."1.35[Treatment of pediatric genital condyloma]. ( Dommergues, C; Quinet, B, 2008)
"Nearly all cervical cancers are associated with the high-risk subtypes of human papillomavirus (HPV) expressing the E6 and E7 oncoproteins."1.33Enhanced antiproliferative effects of alkoxyalkyl esters of cidofovir in human cervical cancer cells in vitro. ( Aldern, KA; Beadle, JR; Corbeil, J; Hostetler, KY; Rought, S; Trahan, J, 2006)
"Human papillomavirus infection is one of the most common and most distressing cutaneous diseases in patients with HIV infection."1.33Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection. ( Kottke, MD; Parker, SR, 2006)
" Complete cures were obtained using 1% (w/v) topical cidofovir at dosing schedules of twice daily for 8 weeks beginning at 4 weeks after CRPV infection, which represents a time when papillomas were clearly visible."1.31In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas. ( Budgeon, LR; Christensen, ND; Kreider, JW; Pickel, MD, 2000)

Research

Studies (100)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (8.00)18.2507
2000's42 (42.00)29.6817
2010's47 (47.00)24.3611
2020's3 (3.00)2.80

Authors

AuthorsStudies
Napolitano, L1
Schroedl, L1
Kerman, A1
Shea, CR1
Solarz, P1
Bodnar, M1
Czech, J1
Mackiewicz-Nartowicz, H1
Sinkiewicz, A1
Szylberg, Ł1
Borowczak, J1
Rutkiewicz, P1
Zwierz, A1
Burduk, P1
Richardson, BE1
Jones, SEF1
Hibbitts, S1
Hurt, CN1
Bryant, D1
Fiander, AN1
Powell, N1
Tristram, AJ1
Carifi, M1
Ciarrocca, K1
Jackson, LL1
De Rossi, SS1
Manickavasagam, J1
Wu, K1
Bateman, ND1
Dikkers, FG4
Clamp, PJ2
Saunders, MW2
Durvasula, VS1
Richter, GT1
Chirilă, M2
Bolboacă, SD1
Moore, JE1
Garcia, A1
Sanyal, S1
Saunders, S1
Portnoy, JE1
Hu, A1
Sataloff, RT2
Grasso, M2
Remacle, M4
Bachy, V1
Van Der Vorst, S1
Lawson, G3
Christensen, ND2
Cladel, NM1
Hu, J1
Balogh, KK1
San Giorgi, MR1
Tjon Pian Gi, RE3
Andrei, G6
Topalis, D3
De Schutter, T3
Snoeck, R12
Murono, S2
Nakanishi, Y2
Tsuji, A2
Endo, K2
Kondo, S2
Wakisaka, N2
Yoshida, H1
Yoshizaki, T2
Liekens, S1
Noppen, S1
Gijsbers, S1
Sienaert, R1
Ronca, R1
Tobia, C1
Presta, M1
Fusconi, M1
Greco, A1
Gallo, A1
Campo, F1
Turchetta, R1
Pagliuca, G1
DE Vincentiis, M1
Milutin Gašperov, N1
Sabol, I1
Planinić, P1
Grubišić, G1
Fistonić, I1
Ćorušić, A1
Grce, M1
Karatayli-Ozgursoy, S1
Bishop, JA1
Hillel, A1
Akst, L1
Best, SR1
Kim, HT1
Baizhumanova, AS1
Zeitels, SM1
Sendagorta, E1
Bernardino, JI1
Álvarez-Gallego, M1
Feíto, M1
Feltes, R1
Beato, MJ1
Pérez-Molina, JA1
Yllescas, M1
Díaz-Almirón, M1
Arribas, JR1
González-García, J1
Herranz, P1
Nogueira, TC1
El Amri, C1
Krečmerová, M1
Naesens, L4
Balzarini, J2
Mertens, B1
Nogueira, T1
Stranska, R1
Pi Sala, N1
Figueras Suriol, A1
Ramió Montero, E1
Drejet, S1
Halum, S1
Brigger, M1
Skopelja, E1
Parker, NP1
Catalani, S1
Palma, F1
Battistelli, S1
Nuvoli, B1
Galati, R1
Benedetti, S1
Meacham, RK1
Thompson, JW1
Carvalho, CM1
Huot, L1
Charlois, AL1
Khalfallah, SA1
Chapuis, F1
Froehlich, P6
Van Pachterbeke, C1
Bucella, D1
Rozenberg, S1
Manigart, Y1
Gilles, C1
Larsimont, D1
Vanden Houte, K1
Reynders, M1
Bossens, M3
Culton, DA1
Morrell, DS1
Burkhart, CN1
Muñoz, RM1
Prado, E1
Cisneros, JM1
Bautista, FJ1
Donne, AJ3
Hampson, L2
He, XT2
Day, PJ1
Salway, F1
Rothera, MP3
Homer, JJ3
Hampson, IN2
Rivière, F1
Gille, T1
Le Tinier, JY1
Gharbi, N1
Khalil, A1
Wislez, M1
Cadranel, J1
Collette, DC1
Zechel, MA1
Ksiazek, J1
Prager, JD1
Sun, GH1
Wood, RE1
Arjmand, EM1
Wierzbicka, M2
Jackowska, J2
Bartochowska, A1
Józefiak, A1
Szyfter, W1
Kędzia, W1
Darwich, E1
Darwich, L1
Cañadas, MP1
Klaustermeier, J1
Ercilla, G1
Alsina-Gibert, M1
Mascaró, JM1
Gáll, T1
Kis, A1
Fehér, E1
Gergely, L1
Szarka, K1
Dietz, A2
Djukic, V1
Eckel, HE1
Friedrich, G3
Golusinski, W2
Hantzakos, A2
Rihkanen, H1
Di Lucca-Christment, J1
Jacobelli, S1
Gressier, L1
Plantier, F1
Laude, H1
Rozenberg, F1
Rosenberg, F1
Morini, JP1
Dallot, A1
Avril, MF1
Dupin, N1
Gormley, RH1
Kovarik, CL1
DeFatta, RA1
Sataloff, JB1
Klaris, GE1
Mikolajczak, S1
Quante, G1
Weissenborn, S1
Wafaisade, A1
Wieland, U1
Lüers, JC1
Klussmann, JP1
Beutner, D1
Fox, PA1
Graupp, M2
Gugatschka, M1
Kiesler, K1
Reckenzaun, E1
Hammer, G1
Derkay, CS1
Volsky, PG1
Rosen, CA1
Pransky, SM1
McMurray, JS1
Chadha, NK1
Duraffour, S1
Mitera, T1
van den Oord, J1
Matthys, P1
Nathan, M1
Ilmarinen, T1
van den Heuvel, ER1
Aaltonen, LM1
Andersen, J1
Brunings, JW1
Ferran Vilà, F1
de Gier, HH1
Horcasitas, R1
Koelmel, JC1
Lindner, F1
Sittel, C1
Weichbold, V1
Coulombeau, B2
Nusa Naiman, A1
Ceruse, P1
Johnson, JA2
Gangemi, JD2
Milczuk, HA1
Ramos, E1
Drachenberg, CB1
Portocarrero, M1
Wali, R1
Klassen, DK1
Fink, JC1
Farney, A1
Hirsch, H1
Papadimitriou, JC1
Cangro, CB1
Weir, MR1
Bartlett, ST1
Bernard, HU1
DeRossi, SS1
Laudenbach, J1
Kendall, KA1
Naiman, AN3
Roger, G1
Gagnieu, MC1
Bordenave, J1
Mathaut, S1
Ayari, S3
Nicollas, R2
Bour, JB2
Garabedian, N1
Toutous-Trellu, L1
Hirschel, B1
Piguet, V1
Schiffer, V1
Saurat, JH1
Pechère, M1
Sirianni, N1
Wang, J1
Ferris, RL1
Derkay, C1
De Clercq, E6
Leyssen, P1
Neyts, J1
Pannecouque, C1
Ying, C1
Hocková, D1
Holý, A1
Lee, JH1
Smith, RJ1
Tasca, RA1
McCormick, M1
Clarke, RW1
Hostetler, KY1
Rought, S1
Aldern, KA1
Trahan, J1
Beadle, JR1
Corbeil, J1
Tan, HH1
Goh, CL1
Abedipour, D1
Fresnel, E1
Kottke, MD1
Parker, SR1
Landry, G1
Colombeau, B1
Shrestha, S1
Wang, C1
Aissani, B1
Wilson, CM1
Tang, J1
Kaslow, RA1
Briand, S1
Milpied, B1
Navas, D1
Thomare, P1
Stalder, JF1
Dommergues, C1
Quinet, B1
Peng, X1
Lang, CM1
Kreider, JW2
Van Cutsem, E1
Van Ranst, M2
Fiten, P1
Opdenakker, G1
Geboes, K1
Janssens, J1
Rutgeerts, P1
Vantrappen, G1
Gross, G1
Hou, J1
Major, EO1
Zabawski, EJ1
Cockerell, CJ1
Taoufik, Y1
Gasnault, J1
Karaterki, A1
Pierre Ferey, M1
Marchadier, E1
Goujard, C1
Lannuzel, A1
Delfraissy, JF1
Dussaix, E1
Orlando, G1
Fasolo, MM1
Beretta, R1
Signori, R1
Adriani, B1
Zanchetta, N1
Cargnel, A1
Noel, JC2
Muller, C1
Davis, MD1
Gostout, BS1
McGovern, RM1
Persing, DH1
Schut, RL1
Pittelkow, MR1
Held, TK1
Biel, SS1
Nitsche, A1
Kurth, A1
Chen, S1
Gelderblom, HR1
Siegert, W1
Dancey, DR1
Chamberlain, DW1
Krajden, M1
Palefsky, J1
Alberti, PW1
Downey, GP1
Calista, D2
Pickel, MD1
Budgeon, LR1
Parent, D1
Delaere, B1
Degreef, H1
Wulfsohn, MS1
Rooney, JF1
Jaffe, HS1
Van Laethem, Y1
De Maubeuge, J1
Clumeck, N1
Mahé, E1
Descamps, V1
Abdulkarim, B1
Sabri, S1
Deutsch, E1
Chagraoui, H1
Maggiorella, L1
Thierry, J1
Eschwege, F1
Vainchenker, W1
Chouaïb, S1
Bourhis, J1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients[NCT01946009]20 participants (Actual)Interventional2013-09-30Completed
TOPical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasm: a Randomized Controlled Trial.[NCT02329171]Phase 39 participants (Actual)Interventional2014-12-31Terminated (stopped due to Insufficient number of participants.)
Efficacy and Safety of Topical Trichloroacetic Acid vs. Electrocautery for the Treatment of Anal Intraepithelial Neoplasia in HIV-positive Patients (TECAIN) - a Randomized Controlled Trial[NCT02615860]560 participants (Actual)Interventional2015-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

18 reviews available for cytosine and Papillomavirus Infections

ArticleYear
Intralesional cidofovir as adjuvant for the successful management of aggressive respiratory papillomatosis in an infant.
    International journal of pediatric otorhinolaryngology, 2013, Volume: 77, Issue:11

    Topics: Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Administration Schedul

2013
Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia.
    Antiviral research, 2015, Volume: 114

    Topics: Animals; Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Cell Proliferation; Cidofovir; C

2015
Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.
    Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2014, Volume: 34, Issue:6

    Topics: Antiviral Agents; Cidofovir; Cytosine; Humans; Organophosphonates; Papillomavirus Infections; Respir

2014
A Systematic Review.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2017, Volume: 156, Issue:3

    Topics: Adult; Angiogenesis Inhibitors; Antiviral Agents; Bevacizumab; Cidofovir; Cytosine; Humans; Injectio

2017
The management of condyloma acuminata in the pediatric population.
    Pediatric annals, 2009, Volume: 38, Issue:7

    Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antiviral Agents; Child; Child, Presch

2009
Novel treatment of atypical human papillomavirus-associated epithelial hyperplasia with cidofovir.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2011, Volume: 69, Issue:9

    Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Anus Neoplasms; Cidofovir; Cytosine; Epithe

2011
Human papillomavirus-related genital disease in the immunocompromised host: Part II.
    Journal of the American Academy of Dermatology, 2012, Volume: 66, Issue:6

    Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents, Phytogenic; Ant

2012
Treatment options for anal intraepithelial neoplasia and evidence for their effectiveness.
    Sexual health, 2012, Volume: 9, Issue:6

    Topics: Adult; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Anus Neoplasms; Cido

2012
Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis.
    International journal of pediatric otorhinolaryngology, 2013, Volume: 77, Issue:3

    Topics: Antiviral Agents; Cidofovir; Cytosine; Humans; Injections, Intralesional; Organophosphonates; Papill

2013
Established and potential strategies against papillomavirus infections.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:2

    Topics: Aminoquinolines; Antimetabolites; Antiviral Agents; Cidofovir; Cytosine; Drug Design; Fluorouracil;

2004
Recurrent respiratory papillomatosis: pathogenesis to treatment.
    Current opinion in otolaryngology & head and neck surgery, 2005, Volume: 13, Issue:6

    Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Cidofovir; Cytosine; Human papillomavirus 11; Human p

2005
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
    American journal of clinical dermatology, 2006, Volume: 7, Issue:1

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Ad

2006
Papillomavirus and treatment.
    Antiviral research, 2006, Volume: 71, Issue:2-3

    Topics: Antiviral Agents; Carcinoma; Chemotherapy, Adjuvant; Cidofovir; Cytosine; Female; Humans; Organophos

2006
Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
    International journal of pediatric otorhinolaryngology, 2008, Volume: 72, Issue:7

    Topics: Antiviral Agents; Cidofovir; Cytosine; Humans; Neoplasm Recurrence, Local; Organophosphonates; Papil

2008
Therapy of human papillomavirus infection and associated epithelial tumors.
    Intervirology, 1997, Volume: 40, Issue:5-6

    Topics: Aminoquinolines; Antineoplastic Agents; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine

1997
Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.
    Journal of the American Academy of Dermatology, 1998, Volume: 39, Issue:5 Pt 1

    Topics: Administration, Cutaneous; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents;

1998
Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature.
    Chest, 2000, Volume: 118, Issue:4

    Topics: Adult; Antiviral Agents; Biopsy; Cidofovir; Cystic Adenomatoid Malformation of Lung, Congenital; Cyt

2000
Cidofovir in the treatment of HPV-associated lesions.
    Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 2001, Volume: 63, Issue:2

    Topics: Administration, Topical; Antiviral Agents; Apoptosis; Cell Division; Cidofovir; Cytosine; Female; Hu

2001

Trials

8 trials available for cytosine and Papillomavirus Infections

ArticleYear
Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: a pilot clinical trial.
    AIDS (London, England), 2016, Jan-02, Volume: 30, Issue:1

    Topics: Administration, Topical; Adult; Antiviral Agents; Anus Neoplasms; Biopsy; Carcinoma in Situ; Cidofov

2016
Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study.
    Gynecologic oncology, 2009, Volume: 115, Issue:1

    Topics: Administration, Topical; Adult; Antineoplastic Agents; Cidofovir; Combined Modality Therapy; Conizat

2009
[Treatment of cutaneous human papilloma virus, poxvirus and herpes simplex virus infections with topical cidofovir in HIV positive patients].
    Annales de dermatologie et de venereologie, 2004, Volume: 131, Issue:5

    Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Cytosine; Female; Herpes Simplex; HIV I

2004
Intermediate-term and long-term results after treatment by cidofovir and excision in juvenile laryngeal papillomatosis.
    The Annals of otology, rhinology, and laryngology, 2006, Volume: 115, Issue:9

    Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modality Therapy;

2006
Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III).
    Journal of medical virology, 2000, Volume: 60, Issue:2

    Topics: Adult; Antiviral Agents; Biopsy; Cervix Uteri; Cidofovir; Conization; Cytosine; Female; Humans; Immu

2000
Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2000, Volume: 14, Issue:6

    Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; C

2000
Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Sep-01, Volume: 33, Issue:5

    Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Male; Middle Aged; Organophosphonates;

2001
[A new antiviral for genito-anal condylomas].
    Presse medicale (Paris, France : 1983), 2002, Mar-16, Volume: 31, Issue:10

    Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; Double

2002

Other Studies

74 other studies available for cytosine and Papillomavirus Infections

ArticleYear
Topical cidofovir for benign human papillomavirus-associated skin lesions.
    Antiviral therapy, 2021, Volume: 26, Issue:6-8

    Topics: Alphapapillomavirus; Cidofovir; Cytosine; Humans; Organophosphonates; Papillomaviridae; Papillomavir

2021
Assessment of immunomodulation and regulation of cell cycle in epithelium and stroma after Cidofovir injection in patients with recurrent respiratory papillomatosis-Pilot study.
    Journal of medical virology, 2023, Volume: 95, Issue:1

    Topics: Antiviral Agents; Cell Cycle; Cidofovir; Cytosine; Epithelium; Humans; Immunomodulation; Laryngeal N

2023
Initial Experience Treating HPV-Related Laryngeal Diseases with Oral Brincidofovir: A Pilot Study.
    The Annals of otology, rhinology, and laryngology, 2021, Volume: 130, Issue:12

    Topics: Administration, Oral; Adult; Alphapapillomavirus; Antiviral Agents; Cytosine; Dose-Response Relation

2021
Human Papillomavirus DNA Methylation Predicts Response to Treatment Using Cidofovir and Imiquimod in Vulval Intraepithelial Neoplasia 3.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Sep-15, Volume: 23, Issue:18

    Topics: Aminoquinolines; Biomarkers; Carcinoma in Situ; Cidofovir; Cytosine; DNA Methylation; DNA, Viral; Dr

2017
Use of cidofovir in recurrent respiratory papillomatosis.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2013, Volume: 270, Issue:7

    Topics: Antiviral Agents; Cytosine; Female; Humans; Male; Organophosphonates; Papillomavirus Infections; Res

2013
Human papillomavirus: the fundamentals of HPV for oral health care providers.
    Journal of the California Dental Association, 2013, Volume: 41, Issue:5

    Topics: Antiviral Agents; Cidofovir; Cytosine; HIV Infections; Humans; Mouth Neoplasms; Organophosphonates;

2013
Treatment of paediatric laryngeal papillomas: web survey of British Association of Paediatric Otolaryngologists.
    The Journal of laryngology and otology, 2013, Volume: 127, Issue:9

    Topics: Anticarcinogenic Agents; Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Health Ca

2013
Letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".
    International journal of pediatric otorhinolaryngology, 2013, Volume: 77, Issue:10

    Topics: Antiviral Agents; Cytosine; Humans; Organophosphonates; Papillomavirus Infections; Respiratory Tract

2013
Response to Dikkers letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".
    International journal of pediatric otorhinolaryngology, 2013, Volume: 77, Issue:10

    Topics: Antiviral Agents; Cytosine; Humans; Organophosphonates; Papillomavirus Infections; Respiratory Tract

2013
Clinical efficiency of quadrivalent HPV (types 6/11/16/18) vaccine in patients with recurrent respiratory papillomatosis.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2014, Volume: 271, Issue:5

    Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; Female; Follow-Up

2014
Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis.
    Journal of voice : official journal of the Voice Foundation, 2013, Volume: 27, Issue:6

    Topics: Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Male; Middle Aged; Organophosphonates; Papill

2013
Use of cidofovir in HPV patients with recurrent respiratory papillomatosis.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2014, Volume: 271, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Injections, I

2014
Formulation of cidofovir improves the anti-papillomaviral activity of topical treatments in the CRPV/rabbit model.
    Antiviral research, 2014, Volume: 108

    Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Chemistry, Pharmaceutical; Cidofovir

2014
The clinical course of recurrent respiratory papillomatosis after the use of cidofovir is influenced by multiple factors.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2015, Volume: 272, Issue:7

    Topics: Cytosine; Female; Humans; Male; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Res

2015
Trends in the management of recurrent respiratory papillomatosis in Japan.
    Auris, nasus, larynx, 2015, Volume: 42, Issue:3

    Topics: Antiviral Agents; Cidofovir; Cytosine; Debridement; Disease Management; Humans; Japan; Laser Therapy

2015
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors.
    Oncotarget, 2015, Mar-10, Volume: 6, Issue:7

    Topics: Animals; Antiviral Agents; Apoptosis; Blotting, Western; Cell Proliferation; Cidofovir; Cytosine; Em

2015
Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer.
    PloS one, 2015, Volume: 10, Issue:6

    Topics: Adult; Biomarkers; Cell Line; Cervix Uteri; CpG Islands; Cytosine; DNA Methylation; DNA, Viral; Fema

2015
Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population.
    The Annals of otology, rhinology, and laryngology, 2016, Volume: 125, Issue:3

    Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma; Cell Transfor

2016
Is recurrent respiratory papillomatosis a manageable or curable disease?
    The Laryngoscope, 2016, Volume: 126, Issue:6

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Chemotherapy, Adjuvant; Child; Cidofovir; Combined Modali

2016
Glottic Cancer: A Metamorphosing Disease.
    The Annals of otology, rhinology, and laryngology, 2016, Volume: 125, Issue:6

    Topics: Adolescent; Adult; Antiviral Agents; Carcinoma, Squamous Cell; Cidofovir; Cytosine; Diagnostic Error

2016
Resistance to the nucleotide analogue cidofovir in HPV(+) cells: a multifactorial process involving UMP/CMP kinase 1.
    Oncotarget, 2016, Mar-01, Volume: 7, Issue:9

    Topics: ATP-Binding Cassette Transporters; Cell Line, Tumor; Cidofovir; Cytidine Triphosphate; Cytosine; Dru

2016
Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
    Auris, nasus, larynx, 2016, Volume: 43, Issue:5

    Topics: Adult; Aged; Antiviral Agents; Cidofovir; Cytosine; Female; Human papillomavirus 6; Humans; Injectio

2016
Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms.
    Oncotarget, 2016, Jul-26, Volume: 7, Issue:30

    Topics: Antiviral Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cidofovir; Cytosine; DNA Damage; Femal

2016
[Intralesional cidofovir in human papilomavirus infection in interdigital spaces].
    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2017, Jan-01, Volume: 41, Issue:n01

    Topics: Antiviral Agents; Cidofovir; Cytosine; Fingers; Humans; Infusions, Intralesional; Male; Middle Aged;

2017
Reduced cell viability and apoptosis induction in human thyroid carcinoma and mesothelioma cells exposed to cidofovir.
    Toxicology in vitro : an international journal published in association with BIBRA, 2017, Volume: 41

    Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Cidofovir; Cyto

2017
Comparison of cidofovir and the measles, mumps, and rubella vaccine in the treatment of recurrent respiratory papillomatosis.
    Ear, nose, & throat journal, 2017, Volume: 96, Issue:2

    Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modality Therapy; Cytosin

2017
Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients.
    Acta oto-laryngologica, 2009, Volume: 129, Issue:4

    Topics: Adult; Antineoplastic Agents; Child; Child, Preschool; Cidofovir; Cytosine; Databases, Factual; Fema

2009
[Cidofovir gel 1% for treating papillomavirus lesions in a patient with congenital immunodeficiency].
    Enfermedades infecciosas y microbiologia clinica, 2010, Volume: 28, Issue:3

    Topics: Anemia, Hemolytic, Congenital; Antiviral Agents; Cidofovir; Cytosine; Female; Fingers; Gels; Hand De

2010
Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.
    Antiviral therapy, 2009, Volume: 14, Issue:7

    Topics: Antiviral Agents; Cell Line; Cell Survival; Cidofovir; Cytosine; Gene Expression Profiling; Gene Exp

2009
Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion.
    Scandinavian journal of infectious diseases, 2011, Volume: 43, Issue:2

    Topics: Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Infusions, Intravenous; Lung; Middle Aged; Or

2011
Inhaled cidofovir as an adjuvant therapy for recurrent respiratory papillomatosis.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2011, Volume: 144, Issue:4

    Topics: Administration, Inhalation; Aerosols; Antineoplastic Agents; Antiviral Agents; Cidofovir; Cytosine;

2011
Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2011, Volume: 268, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Cidofovir; Cohort Studies; Cyto

2011
New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir.
    Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:2

    Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir;

2011
Virological failure of intralesional cidofovir therapy in recurrent respiratory papillomatosis is not associated with genetic or epigenetic changes of HPV11: complete genome comparison of sequential isolates.
    Antiviral research, 2011, Volume: 92, Issue:2

    Topics: Antiviral Agents; Cidofovir; Cytosine; DNA Methylation; DNA, Viral; Epigenesis, Genetic; Genome, Vir

2011
Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2012, Volume: 269, Issue:2

    Topics: Adverse Drug Reaction Reporting Systems; Antiviral Agents; Cidofovir; Cytosine; Injections, Intrales

2012
Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment.
    AIDS (London, England), 2012, Feb-20, Volume: 26, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Carcinoma, Squamous Cell; Cidofovir;

2012
Laryngeal papilloma.
    Ear, nose, & throat journal, 2012, Volume: 91, Issue:5

    Topics: Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Humans; Injections, Intralesional;

2012
The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2012, Volume: 269, Issue:12

    Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; DNA, Viral; Female; Human papillomavirus 11; Human pap

2012
Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2013, Volume: 270, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cy

2013
Current use of intralesional cidofovir for recurrent respiratory papillomatosis.
    The Laryngoscope, 2013, Volume: 123, Issue:3

    Topics: Antiviral Agents; Chemotherapy, Adjuvant; Cidofovir; Cross-Sectional Studies; Cytosine; Humans; Inje

2013
Cidofovir treatment improves the pathology caused by the growth of human papillomavirus-positive cervical carcinoma xenografts in athymic nude mice.
    Cancer letters, 2013, Feb-28, Volume: 329, Issue:2

    Topics: Animals; Antineoplastic Agents; Brain; Cachexia; Carcinoma; Cell Line, Tumor; Cidofovir; Cytokines;

2013
Treatment of anal intraepithelial neoplasia: has it come of age?
    AIDS (London, England), 2013, Feb-20, Volume: 27, Issue:4

    Topics: Antiviral Agents; Anus Neoplasms; Carcinoma in Situ; Cidofovir; Cytosine; Female; HIV Infections; Hu

2013
Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2013, Volume: 270, Issue:5

    Topics: Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Female; Head and Neck Neoplasms; H

2013
Anti-cancer agents. Will cidofovir be useful against cervical lesions?
    TreatmentUpdate, 2000, Volume: 12, Issue:6

    Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Organophosphonates; Organophosphorus C

2000
[Anti-viral injectable treatment (cidofovir) in laryngeal papillomatosis].
    Revue de laryngologie - otologie - rhinologie, 2002, Volume: 123, Issue:5

    Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modality Therapy;

2002
Alpha interferon augments cidofovir's antiviral and antiproliferative activities.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:6

    Topics: Antiviral Agents; Blotting, Western; Cell Line, Transformed; Cidofovir; Colony Count, Microbial; Cyc

2003
Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2003, Volume: 128, Issue:6

    Topics: Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; Female; Humans; Infant; Injections,

2003
BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program.
    Clinical transplants, 2002

    Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Humans; Immunosuppressive Agents; Incidence; Kidney

2002
The management of oral human papillomavirus with topical cidofovir: a case report.
    Cutis, 2004, Volume: 73, Issue:3

    Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Cytosine; Diagnosis, Differential; Gels

2004
Current treatment for laryngeal papillomatosis.
    Current opinion in otolaryngology & head and neck surgery, 2004, Volume: 12, Issue:3

    Topics: Adult; Antineoplastic Agents; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modalit

2004
Cidofovir plasma assays after local injection in respiratory papillomatosis.
    The Laryngoscope, 2004, Volume: 114, Issue:7

    Topics: Adult; Aged; Antiviral Agents; Area Under Curve; Child; Child, Preschool; Chromatography, High Press

2004
Antiviral activity of Cidofovir on a naturally human papillomavirus-16 infected squamous cell carcinoma of the head and neck (SCCHN) cell line improves radiation sensitivity.
    Oral oncology, 2005, Volume: 41, Issue:4

    Topics: Adult; Antiviral Agents; Blotting, Western; Carcinoma, Squamous Cell; Cell Survival; Cidofovir; Cyto

2005
Cidofovir for recurrent respiratory papillomatosis (RRP): a re-assessment of risks.
    International journal of pediatric otorhinolaryngology, 2005, Volume: 69, Issue:11

    Topics: Animals; Antiviral Agents; Carcinogens; Child; Cidofovir; Cytosine; Drug Approval; Humans; Neoplasm

2005
Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
    Nucleosides, nucleotides & nucleic acids, 2005, Volume: 24, Issue:5-7

    Topics: Adenoviridae; Adenoviridae Infections; Animals; Anti-HIV Agents; Antiviral Agents; Cell Line; Cidofo

2005
British Association of Paediatric Otorhinolaryngology members experience with recurrent respiratory papillomatosis.
    International journal of pediatric otorhinolaryngology, 2006, Volume: 70, Issue:7

    Topics: Anticarcinogenic Agents; Antiviral Agents; Child; Cidofovir; Cytosine; Databases, Factual; Health Ca

2006
Enhanced antiproliferative effects of alkoxyalkyl esters of cidofovir in human cervical cancer cells in vitro.
    Molecular cancer therapeutics, 2006, Volume: 5, Issue:1

    Topics: Antineoplastic Agents; Cell Proliferation; Cidofovir; Cytosine; Drug Screening Assays, Antitumor; Es

2006
Natural history of adult-onset laryngeal papillomatosis following multiple cidofovir injections.
    The Annals of otology, rhinology, and laryngology, 2006, Volume: 115, Issue:3

    Topics: Adult; Antiviral Agents; Biopsy; Cidofovir; Cytosine; DNA, Viral; Female; Follow-Up Studies; Human p

2006
Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection.
    Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:3

    Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Humans; Injections, Intravenous; Male; Organophosphona

2006
Effects of cidofovir on a novel cell-based test system for recurrent respiratory papillomatosis.
    Head & neck, 2007, Volume: 29, Issue:8

    Topics: Antiviral Agents; Blotting, Western; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Flow Cyt

2007
Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2007, Volume: 16, Issue:8

    Topics: Adolescent; Adult; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Child; Cohort Studies; Cytosine

2007
1% topical cidofovir used as last alternative to treat viral infections.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2008, Volume: 22, Issue:2

    Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir;

2008
[Treatment of pediatric genital condyloma].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2008, Volume: 15, Issue:4

    Topics: Adult; Aminoquinolines; Antiviral Agents; Child; Cidofovir; Condylomata Acuminata; Cytosine; Humans;

2008
Methylation of cottontail rabbit papillomavirus DNA and tissue-specific expression in transgenic rabbits.
    Virus research, 1995, Volume: 35, Issue:1

    Topics: 5-Methylcytosine; Animals; Animals, Genetically Modified; Cottontail rabbit papillomavirus; Cytosine

1995
Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.
    Journal of medical virology, 1995, Volume: 45, Issue:2

    Topics: Aged; Antiviral Agents; Cidofovir; Cytosine; Esophageal Neoplasms; Female; Humans; Hypopharyngeal Ne

1995
The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line.
    Journal of neurovirology, 1998, Volume: 4, Issue:4

    Topics: Anti-HIV Agents; Antiviral Agents; Brain; Cells, Cultured; Cidofovir; Cytarabine; Cytosine; DNA, Vir

1998
Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy.
    The Journal of infectious diseases, 1998, Volume: 178, Issue:6

    Topics: AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count

1998
Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:5

    Topics: Antiviral Agents; Cell Cycle; Cell Transformation, Viral; Cells, Cultured; Cidofovir; Cytosine; Huma

1999
Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
    AIDS (London, England), 1999, Oct-01, Volume: 13, Issue:14

    Topics: Administration, Topical; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Condylo

1999
Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy.
    Journal of the American Academy of Dermatology, 2000, Volume: 43, Issue:2 Pt 2

    Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Biopsy; Cid

2000
Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir.
    Bone marrow transplantation, 2000, Volume: 26, Issue:3

    Topics: Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytomegalovirus; Cytomegalovirus Infections; Cytosi

2000
Resolution of recalcitrant human papillomavirus gingival infection with topical cidofovir.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2000, Volume: 90, Issue:6

    Topics: Anti-Infective Agents, Local; Antiviral Agents; Cidofovir; Cytosine; Gingival Diseases; HIV Infectio

2000
In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas.
    Antiviral research, 2000, Volume: 48, Issue:2

    Topics: Animals; Antiviral Agents; Cidofovir; Cottontail rabbit papillomavirus; Cytosine; Disease Models, An

2000
Treatment of a bowenoid papulosis of the penis with local applications of cidofovir in a patient with acquired immunodeficiency syndrome.
    Archives of internal medicine, 2001, Oct-22, Volume: 161, Issue:19

    Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Antiviral Agents; Bowen's Diseas

2001
Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.
    Oncogene, 2002, Apr-04, Volume: 21, Issue:15

    Topics: Animals; Antiviral Agents; Carcinoma; Cell Division; Cidofovir; Cyclin A; Cyclin-Dependent Kinase In

2002